dupilumab

Documents about dupilumab

• Dupilumab Phase 4 Study#1377656ClinicalTrials.gov
• Withdrawal of Dupilumab in Severe Asthma#1485418ClinicalTrials.gov
• Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus#1161624ClinicalTrials.gov
• Dupilumab for recalcitrant prurigo nodularis: Case report#335990RCAAP
• Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants#862832ClinicalTrials.gov
• Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis#1437910ClinicalTrials.gov
• Successful Treatment of Severe Adult Linear IgA Dermatosis Using Dupilumab#68405HAL (France)
• The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction#854123ClinicalTrials.gov
• Dupilumab’s impact on blood parameters in nasal polyposis: 18-month follow-up in real life#644265IRIS
• Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema#836557ClinicalTrials.gov
• Dupilumab as an effective therapeutic option in a severe flare of Hailey-Hailey disease triggered by scabies infestation#1266697IRIS
• Drug-induced sarcoidosis-like reaction following IL-4/IL-13 receptor blockade by dupilumab#194804OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Effect of Dupilumab on Aspirin Intolerance#846123ClinicalTrials.gov
• Dupilumab for Patients with Allergic Fungal Rhinosinusitis#1081219ODU Digital Commons
• Regeneron AA Multicenter (Dupilumab)#1197612ClinicalTrials.gov
• The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients#1370466ClinicalTrials.gov
• Dupilumab Compassionate Use Study#895193ClinicalTrials.gov
• The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world Study#1429712ClinicalTrials.gov
• Dupilumab in Japanese Patients With Atopic Dermatitis#1058946ClinicalTrials.gov
• Evaluation of Dupilumab in Children With Uncontrolled Asthma#1115030ClinicalTrials.gov
• Dupilumab-Related Hypereosinophilia in Patients Treated for Type 2 Diseases: Evidence from a 24-Month Prospective Real-Life Study#456865IRIS
• Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)#825602ClinicalTrials.gov
• Dupilumab Skin Barrier Function Study in Atopic Dermatitis#1352156ClinicalTrials.gov
• Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.#982264ClinicalTrials.gov
• Dupilumab Therapy in Nephrotic Syndrome in Children#1282123ClinicalTrials.gov
• Dupilumab De-escalation in Pediatric Atopic Dermatitis#835866ClinicalTrials.gov
• SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"#891753ClinicalTrials.gov
• Dupilumab_Metastatic NSCLC#1088916ClinicalTrials.gov
• Dupilumab in Chronic Rhinosinusitis Without Nasal Polyps: Randomized Phase 2 Trial (ORION)#626206ODU Digital Commons
• Molecular Signatures of Cutaneous Dupilumab Response#806292ClinicalTrials.gov
• Real Life Experience Survey of Dupilumab in the Netherlands#813451ClinicalTrials.gov
• Dupilumab for Aspirin-exacerbated Respiratory Disease#884009ClinicalTrials.gov
• Study of REGN3500 and Dupilumab in Patients With Asthma#1009039ClinicalTrials.gov
• Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)#871631ClinicalTrials.gov
• Early-onset Dupilumab Effects in CRSwNP#894191ClinicalTrials.gov
• Dupilumab in Eosinophilic Gastritis#905183ClinicalTrials.gov
• Open-label Study of Dupilumab in Patients With Atopic Dermatitis#1280853ClinicalTrials.gov
• Cholinergic Urticaria - Efficacy of Dupilumab#1439134ClinicalTrials.gov
• A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)#1310524ClinicalTrials.gov
• Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy#1056919ClinicalTrials.gov
• Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study#1151830ClinicalTrials.gov
• Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)#1162187ClinicalTrials.gov
• Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid#1310117ClinicalTrials.gov
• Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis#807778ClinicalTrials.gov
• Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)#825225ClinicalTrials.gov
• Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis#1292372ClinicalTrials.gov
• Dupilumab in Chronic Spontaneous Urticaria#1418217ClinicalTrials.gov
• Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases#290987ClinicalTrials.gov
• Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China#803912ClinicalTrials.gov
• Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis#832448ClinicalTrials.gov